Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Cellular and Molecular Medicine is Scopus-indexed (Q2, CiteScore 6.9), WoS SCIE, DOAJ. Published by John Wiley and Sons Inc.
Checked against the index lists dated .
ISSN 1582-1838Verify ISSN ↗1582-4934Verify ISSN ↗
Publisher: John Wiley and Sons Inc
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Molecular Medicine | 60 / 179 | 66th | Q2 |
| Cell Biology | 113 / 289 | 61st | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2000–present, best quartile Q2, CiteScore 6.9.
Journal of Cellular and Molecular Medicine is Q2 in Molecular Medicine (rank 60 of 179) and Q2 in Cell Biology (rank 113 of 289), by CiteScore 2025.
Journal of Cellular and Molecular Medicine is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 6.9, which places it in quartile Q2 at the 66th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.142, quartile Q2, with an H-index of 172.
The publisher lists an article processing charge of about US$5,210 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Journal of Cellular and Molecular Medicine is published by John Wiley and Sons Inc. Its print ISSN is 1582-1838 and its online ISSN is 1582-4934.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Journal of Cellular and Molecular Medicine has an h-index of 187 and a 2-year mean of 4.47 citations per paper (OpenAlex). Its Scopus CiteScore is 6.9, quartile Q2. On 2-year citations it ranks #50 of 177 Scopus journals in Molecular Medicine.
Journal of Cellular and Molecular Medicine published 712 papers in 2025; its busiest recent year was 2020 with 1,271. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2026), authors are most often from China (66%), United States (5.5%) and United Kingdom (2.9%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 149 retracted papers are recorded (14.5 per 1,000 papers). The Problematic Paper Screener flags 13 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.